On Tuesday, Ventyx Biosciences Inc (NASDAQ: VTYX) was 6.70% up from the session before settling in for the closing price of $3.73. A 52-week range for VTYX has been $0.78 – $3.91.
Annual sales at Healthcare sector company slipped by -87.13% over the past five years. When this article was written, the company’s average yearly earnings per share was at 15.23%. With a float of $63.19 million, this company’s outstanding shares have now reached $71.23 million.
Let’s look at the performance matrix of the company that is accounted for 82 employees.
Ventyx Biosciences Inc (VTYX) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Ventyx Biosciences Inc stocks. The insider ownership of Ventyx Biosciences Inc is 11.39%, while institutional ownership is 62.31%. The most recent insider transaction that took place on Apr 02 ’25, was worth 2,019. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 1,887 shares at a rate of $1.07, taking the stock ownership to the 467,226 shares. Before that another transaction happened on Dec 27 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 21,119 for $2.36, making the entire transaction worth $49,841. This insider now owns 464,582 shares in total.
Ventyx Biosciences Inc (VTYX) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.5 earnings per share (EPS) during the time that was better than consensus figure (set at -0.51) by 0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.46 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 15.23% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 0.85% during the next five years compared to -87.13% drop over the previous five years of trading.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
You can see what Ventyx Biosciences Inc (VTYX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 19.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.68, a number that is poised to hit -0.45 in the next quarter and is forecasted to reach -1.92 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Ventyx Biosciences Inc (NASDAQ: VTYX) saw its 5-day average volume 2.79 million, a positive change from its year-to-date volume of 1.32 million. As of the previous 9 days, the stock’s Stochastic %D was 85.39%.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 97.62%, which indicates a significant increase from 96.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.31 in the past 14 days, which was higher than the 0.21 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.72, while its 200-day Moving Average is $2.06. Nevertheless, the first resistance level for the watch stands at $4.14 in the near term. At $4.30, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.55. If the price goes on to break the first support level at $3.73, it is likely to go to the next support level at $3.48. Assuming the price breaks the second support level, the third support level stands at $3.32.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
There are 71,309K outstanding shares of the company, which has a market capitalization of 283.81 million. As of now, sales total 0 K while income totals -135,120 K. Its latest quarter income was 0 K while its last quarter net income were -26,990 K.
